• Pharmaceutical and Biotech Investors
    Independent Research. Valuations. Due Diligence. M&A. Exits.
    Investments in Pharmaceuticals
    & Biotech

Pharmaceutical and Biotech Investors Financing
Pharmaceutical & Biotech Companies

Financing

The Pharma & Biotech market has generated very attractive returns for many investors, but at the same time has produced losses to other investors. The sector contains a large number of very-high risk companies, many of which are founded on weak foundations and pursuing projects that are unlikely to either reach the market or to be seen as attractive opportunities by big pharma companies for commercialisation. The professional large investors recently focus much more on mature companies with products and a pipeline.

Small, private companies may be able to progress development of their compounds or technologies up to a point, but are very unlikely to be able to commercialise pharmaceutical products on their own on a worldwide basis, as they will not be able to set up the infrastructure for marketing and distribution. As a result, the vast majority of biotech companies will need corporate deals with pharma companies that have the means to commercialise on a large scale and around the world.


Market Research and Analysis

Commercial Evaluation

Due Diligence

Industry Contacts

Deal Sourcing

Exiting through corporate deals
Investors Life Scienes

Supporting Professional Investors in the Sector


Considering going into an investment?
Needing independent research?
Wanting a corporate deal for a portfolio company?
Planning to exit an investment?

Industry Experience, Proven Track Record, Highly-Capable and Results-Driven

We can assist investors' portfolio companies deliver corporate deals that may facilitate exit and provide validation for the public markets. Investing in the Life Sciences sector is inherently a high risk process.
Expert industry knowledge is essential to mitigate risk and ensure the right decisions are made.

We are a Life Sciences advisory UK company based in London, assisting companies and investors in Pharma, Biotech, MedTech and HealthTech. We specialise in providing full-service support in Business Development & Licensing deals, Product Development, Financing, Commercialisation and Communications.

Core Areas

Contact Us


Address:
DyoDelta Biosciences Ltd
33 St James's Square
London SW1Y 4JS
U.K.
Phone: +44 20 3239 3022
Email: enquiries @ dyodelta . com

[remove spaces between words]